February 7, 2019 / 10:17 PM / 8 months ago

Alexion reaches $13 million deal in U.S. drug charity kickback probe

Alexion Pharmaceuticals Inc, the maker of an expensive blood disorder treatment, has agreed to pay $13 million to resolve a U.S. Department of Justice probe into its financial support of charities that help Medicare patients cover out-of-pocket drug costs.

Boston-based Alexion disclosed the tentative settlement on Wednesday in regulatory filing, becoming the latest company to strike a deal in the industrywide investigation of drugmakers’ support of patient assistance charities.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2MTvVjO

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below